- Home
- EDUC vs MRKR Comparison
EDUC vs MRKR Comparison
Compare EDUC & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDUC
- MRKR
- Stock Information
- Founded
- EDUC 1965
- MRKR N/A
- Country
- EDUC United States
- MRKR United States
- Employees
- EDUC N/A
- MRKR N/A
- Industry
- EDUC Consumer Specialties
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- EDUC Consumer Discretionary
- MRKR Health Care
- Exchange
- EDUC Nasdaq
- MRKR Nasdaq
- Market Cap
- EDUC 13.4M
- MRKR 11.6M
- IPO Year
- EDUC N/A
- MRKR N/A
- Fundamental
- Price
- EDUC $1.34
- MRKR $0.93
- Analyst Decision
- EDUC
- MRKR Strong Buy
- Analyst Count
- EDUC 0
- MRKR 2
- Target Price
- EDUC N/A
- MRKR $10.25
- AVG Volume (30 Days)
- EDUC 742.1K
- MRKR 156.4K
- Earning Date
- EDUC 10-09-2025
- MRKR 11-14-2025
- Dividend Yield
- EDUC N/A
- MRKR N/A
- EPS Growth
- EDUC N/A
- MRKR N/A
- EPS
- EDUC N/A
- MRKR N/A
- Revenue
- EDUC $29,415,900.00
- MRKR $5,388,071.00
- Revenue This Year
- EDUC N/A
- MRKR N/A
- Revenue Next Year
- EDUC N/A
- MRKR $9.06
- P/E Ratio
- EDUC N/A
- MRKR N/A
- Revenue Growth
- EDUC N/A
- MRKR 44.55
- 52 Week Low
- EDUC $0.92
- MRKR $0.81
- 52 Week High
- EDUC $2.11
- MRKR $5.95
- Technical
- Relative Strength Index (RSI)
- EDUC 44.81
- MRKR 46.37
- Support Level
- EDUC $1.29
- MRKR $0.84
- Resistance Level
- EDUC $1.73
- MRKR $1.02
- Average True Range (ATR)
- EDUC 0.12
- MRKR 0.05
- MACD
- EDUC -0.02
- MRKR -0.00
- Stochastic Oscillator
- EDUC 15.91
- MRKR 46.05
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.